Neuropharmacy on-demand: myasthenia gravis

Course New


This is a fully virtual course including 6 on demand sessions. Delegates will be able to access sessions, presentation slides and other resources for 12 months after registration with their website account. This course is for healthcare professionals only.


Growing NHS workforce pressures and a rapidly changing treatment neurology landscape mean it has never been more important to maximise the role of the pharmacist in multidisciplinary teams.

Imminently, further drugs specifically designed to treat myasthenia gravis (MG) are expected to be approved and made available, and pharmacists like you will play a key role in ensuring access and safe use of these treatments.

MG affects anywhere between 15 and 33 people in every 100,000 (MDUK; Carey 2021) and thousands of people may become eligible for groundbreaking treatment in the coming months.

Overview of the education

Covering everything a pharmacist needs to know about MG and working as part of a team to support someone living with it, this free on demand course will:

  • equip you with the knowledge and expertise you need to understand MG
  • support you to work effectively as part of the multidisciplinary team
  • help you understand how to medically manage and optimally treat people living with MG

Through expert speakers, patient stories, and case discussions, the course unpicks diagnosis and management from a neuropharmacy perspective and upskills delegates in optimising treatment options, including the brand new treatments expected in 2024. With collaborative presentations from multidisciplinary team members, this course will also look at different forms of effective working to manage resources and support people with MG.

'The only educational course dedicated to pharmacists specialising in neurosciences, delivered by colleagues from a range of professions. This course highlights and expands the role we play in the patient pathway and in supporting our MDT colleagues.'

Joela Mathews, lead neuroscience pharmacist for Barts Health NHS Trust


Download now (NPMGOD1-Neuropharmacy-on-demand-MG-programme.pdf)
Who is this course for?

Designed for pharmacy professionals who want to develop expertise in myasthenia gravis (MG) this course is ideal for pharmacists who are:

  • new to working as part of a neurology team,
  • interested in developing this role and collaboration in their area,
  • keen to update their understanding of the latest medication and treatment profiles available.

This course is for UK healthcare professionals only.

How is the course taught?

The fully virtual course is accessed in the delegates' own time via our designated online learning portal. The virtual sessions are all available at once, meaning you can give yourself a solid weekend of learning or spread the course out over weeks or even months, if needed. You can choose the access that optimises your learning experience and fits with your other commitments.

Delegates are supported with additional papers, tools and resources shared online as well, each individual will be equipped to complete the course in the way that Delegates will be able to access the course resources for 12 months after registration with their website account.

When you finish the course, you will receive a certificate of completion to add to your portfolio.

Cost of the course

This course is fully funded for UK healthcare professionals only.

If you require more information do not hesitate to contact us: events@neurologyacademy.org

Book your place now
Register now
Developing neuropharmacists, supporting collaborative care

Knowledgeable pharmacists can initiate or support new treatment pathways, play an important role in patient education, medicine adherence, efficacy and safety, and provide advice to other healthcare professionals involved in the person's care. This Academy recognises the value of this essential role, and seeks to enhance pharmacist's clinical skills and build their confidence in managing a range of neurological conditions.